NCT03956121View on ClinicalTrials.gov

Magnesium Sulfate (MgSO4) and Fetal Heart Rate (FHR) in Case of Prematurity

CompletedOBSERVATIONAL
Enrollment

57

Participants

Timeline

Start Date

May 4, 2018

Primary Completion Date

September 2, 2018

Study Completion Date

March 2, 2019

Conditions
Fetal Neuroprotection
Interventions
OTHER

injection of magnesium sulfate

The intervention consists to perform a study of the usual fetal heart rate with, in addition, comparison analysis of the short-term variability before and after injection of magnesium sulfate in the exposed group. Two successive short-term variability analyzes will be performed in fetuses of the control group.

Trial Locations (1)

Unknown

Damien JOLLY, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER

NCT03956121 - Magnesium Sulfate (MgSO4) and Fetal Heart Rate (FHR) in Case of Prematurity | Biotech Hunter | Biotech Hunter